Price
CHART BY
Frequently asked questions
What is Cooper's market capitalization?
The market capitalization of Cooper is $17.69B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Cooper's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Cooper is 45.20. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Cooper?
Cooper's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $1.956. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Cooper's stock?
Currently, 21 analysts cover Cooper's stock, with a consensus target price of $115.00. Analyst ratings provide insights into the stock's expected performance.
What is Cooper's revenue over the trailing twelve months?
Over the trailing twelve months, Cooper reported a revenue of $3.90B.
What is the EBITDA for Cooper?
Cooper's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $1.08B. EBITDA measures the company's overall financial performance.
What is the free cash flow of Cooper?
Cooper has a free cash flow of $288.10M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Cooper have, and what sector and industry does it belong to?
Cooper employs approximately 16,000 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of Cooper's shares?
The free float of Cooper is 198.67M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $17.69B
- EPS (TTM)
- $1.956
- Free Float
- 198.67M
- P/E ratio (TTM)
- 45.20
- Revenue (TTM)
- $3.90B
- EBITDA (TTM)
- $1.08B
- Free Cashflow (TTM)
- $288.10M
Pricing
- 1D span
- $87.69$88.97
- 52W span
- $84.79$112.34
Analyst Ratings
The price target is $115.00 and the stock is covered by 21 analysts.
Buy
12
Hold
8
Sell
1
Information
The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.
- Employees
- 16,000
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- US2166485019
- Primary Ticker
- COO
Knockouts
Finance data from FactSet